4
Changes in Ownership
Altimmune, Inc. Filed Acc 0000899243-17-012361
Options or other derivatives
- Chief Scientific Officer acquired 84,267 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Roberts M Scot Chief Scientific Officer | 2017-05-04 | Grant or award · Stock Option (option to buy) | +55,120 | 55,120 | D: show line 1 in the form | ||
| Roberts M Scot Chief Scientific Officer | 2017-05-04 | Grant or award · Stock Option (option to buy) | +8,956 | 8,956 | D: show line 2 in the form | ||
| Roberts M Scot Chief Scientific Officer | 2017-05-04 | Grant or award · Stock Option (option to buy) | +8,956 | 8,956 | D: show line 3 in the form | ||
| Roberts M Scot Chief Scientific Officer | 2017-05-04 | Grant or award · Stock Option (option to buy) | +11,235 | 11,235 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…